左捆分支区域节奏与心脏再同步的双心室节奏:一个系统的审查和元分析
Amman Yousaf1, Soban Ahmad2, Joshua Peltz2
1Department of Medicine, McLaren Flint-Michigan State University, Flint, Michigan.
Heart rhythm O2
|November 30, 2023
概括
左捆支部区域节奏 (LBBAP) 显著改善心脏功能,并减少住院治疗与心脏衰竭患者的双心室节奏 (BiVP) 相比. 此外,LBBAP还提供了更好的生存率和程序效率.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 心脏衰竭管理的管理
背景情况:
- 左捆分支区域节奏 (LBBAP) 显示了比传统的双心室节奏 (BiVP) 更大的生理益处的潜力.
- 有限的比较数据存在于LBBAP与BiVP在患有系统性心力衰竭 (HF) 的患者的疗效.
研究的目的:
- 为了比较LBBAP与BiVP的可行性,电机学和临床结果.
- 评估LBBAP作为潜在的优越节奏策略,心力衰竭患者.
主要方法:
- 从多个数据库 (PubMed,Embase,Google Scholar,Scopus,CENTRAL) 进行研究的系统审查,截至2023年5月.
- 超分析计算风险比率 (RR) 和标准化平均差异 (SMD) 以95%的置信区间 (CI).
- 包括12项涉及3004名患者的研究 (1242名LBBAP,1762名BiVP).
主要成果:
- LBBAP显著改善了左心室喷射分数 (SMD 0.40),心声回应 (RR 1.19) 和纽约心脏协会功能类 (SMD -0.44).
- LBBAP降低了QRS持续时间 (SMD -0.90) 和左心室终端-扩张直径 (SMD -0.31),减少了HF住院 (RR 0.72) 和改善了生存率 (RR 0.73).
- 与BiVP相比,LBBAP显示了更短的光镜时间和更低的植入和6个月的节奏值.
结论:
- 与BiVP相比,LBBAP与缩性HF患者的优异电机学和临床结果有关.
- 使用LBBAP的主要改善包括增强左心室功能,减少心力衰竭住院治疗,以及更好的整体存活率.
- LBBAP提供了一个有前途的替代节奏策略,用于管理心性心力衰竭.
关键词:
两人的BiVP BiVP双管节奏是双管节奏的节奏.在CRT中,CRT可以在CRT中使用.心脏再同步治疗心脏再同步治疗心脏衰竭是因为心脏衰竭.住院治疗 住院治疗LBBAP LBBAP 这是一个很好的方法.左捆分支区块区域步调调节的步调.更多相关视频
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
14.8K
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
633
相关概念视频
Electrophysiology of Normal Cardiac Rhythm
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Conduction System of the Heart
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
